What is Eikon Therapeutics, Inc. 's market cap?

Eikon Therapeutics, Inc. (EIKN) has a market capitalization of $521.4M and trades on XNAS.

Where is Eikon Therapeutics, Inc. headquartered?

Eikon Therapeutics, Inc. is headquartered in United States of America. It has been publicly traded since 2026.

Eikon Therapeutics, Inc.

EIKN

Eikon Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Roger Perlmutter, with a market cap of $521.4M.

Market cap

$521.35M-32.8%

Table of contents

Earnings

Q4 2025 report

March 30, 2026

EPS-$27.00Miss by $23.44

Read the full report

Next report

Aug 10, 2026 (in a month)

EPS estimate-$1.61

Financials

Q4 2025

Income statement

See full

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Balance sheet

See full

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Cash flow

See full

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Profile

CountryUnited States of America

Listed2026

CEORoger Perlmutter

SectorHealthcare

IndustryBiotechnology

Websiteeikontx.com

FilingsSEC EDGAR

Questions, answered.

What is Eikon Therapeutics, Inc. 's market cap?: Eikon Therapeutics, Inc. (EIKN) has a market capitalization of $521.4M and trades on XNAS.
Where is Eikon Therapeutics, Inc. headquartered?: Eikon Therapeutics, Inc. is headquartered in United States of America. It has been publicly traded since 2026.